Defining optimal permeant characteristics for ultrasound‐mediated gastrointestinal delivery

[1]  Robert Langer,et al.  Ultrasound-Mediated Delivery of RNA to Colonic Mucosa of Live Mice. , 2017, Gastroenterology.

[2]  S. Mitragotri,et al.  Role of nanoparticle size, shape and surface chemistry in oral drug delivery. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[3]  R. Langer,et al.  A Janus Mucoadhesive and Omniphobic Device for Gastrointestinal Retention , 2016, Advanced healthcare materials.

[4]  Giovanni Traverso,et al.  Low-frequency ultrasound for drug delivery in the gastrointestinal tract , 2016, Expert opinion on drug delivery.

[5]  R. Langer,et al.  Of microneedles and ultrasound: Physical modes of gastrointestinal macromolecule delivery , 2016, Tissue barriers.

[6]  R. Klopfleisch,et al.  Colonic gene silencing using siRNA-loaded calcium phosphate/PLGA nanoparticles ameliorates intestinal inflammation in vivo. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[7]  Daniel G. Anderson,et al.  Ultrasound-mediated gastrointestinal drug delivery , 2015, Science Translational Medicine.

[8]  Susan Hua,et al.  Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: selective targeting to diseased versus healthy tissue. , 2015, Nanomedicine : nanotechnology, biology, and medicine.

[9]  Samir Mitragotri,et al.  Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies , 2014, Nature Reviews Drug Discovery.

[10]  J. Karp,et al.  A single localized dose of enzyme-responsive hydrogel improves long-term survival of a vascularized composite allograft , 2014, Science Translational Medicine.

[11]  R. Langer,et al.  Transepithelial Transport of Fc-Targeted Nanoparticles by the Neonatal Fc Receptor for Oral Delivery , 2013, Science Translational Medicine.

[12]  M. Johansson,et al.  The gastrointestinal mucus system in health and disease , 2013, Nature Reviews Gastroenterology &Hepatology.

[13]  L. Zubkov,et al.  Finite element static displacement optimization of 20-100 kHz flexural transducers for fully portable ultrasound applicator. , 2013, Ultrasonics.

[14]  D. Bhowmik,et al.  TRANSDERMAL DRUG DELIVERY SYSTEMS , 2013 .

[15]  Robert Langer,et al.  Rapid skin permeabilization by the simultaneous application of dual-frequency, high-intensity ultrasound. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[16]  Laura M Ensign,et al.  Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers. , 2012, Advanced drug delivery reviews.

[17]  Kullervo Hynynen,et al.  Overview of Therapeutic Ultrasound Applications and Safety Considerations , 2012, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[18]  Zhirong Zhang,et al.  Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport. , 2012, Biomaterials.

[19]  R. Langer,et al.  A physical mechanism to explain the delivery of chemical penetration enhancers into skin during transdermal sonophoresis - Insight into the observed synergism. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[20]  Robert Langer,et al.  Ultrasound-mediated transdermal drug delivery: mechanisms, scope, and emerging trends. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[21]  R. Langer,et al.  Application of the aqueous porous pathway model to quantify the effect of sodium lauryl sulfate on ultrasound-induced skin structural perturbation. , 2011, Journal of pharmaceutical sciences.

[22]  Jiun-Jie Wang,et al.  Self‐Assembled pH‐Sensitive Nanoparticles: A Platform for Oral Delivery of Protein Drugs , 2010 .

[23]  Didier Merlin,et al.  Orally delivered thioketal nanoparticles loaded with TNF-α-siRNA target inflammation and inhibit gene expression in the intestines. , 2010, Nature materials.

[24]  Nadine Barrie Smith,et al.  Noninvasive Ultrasonic Glucose Sensing with Large Pigs (∼200 Pounds) Using a Lightweight Cymbal Transducer Array and Biosensors , 2009 .

[25]  B. Fu,et al.  Non-invasive measurement of solute permeability in cerebral microvessels of the rat. , 2009, Microvascular research.

[26]  R. Cone,et al.  Barrier properties of mucus. , 2009, Advanced drug delivery reviews.

[27]  Robert Langer,et al.  Transdermal drug delivery , 2008, Nature Biotechnology.

[28]  Ronald A. Roy,et al.  Applications of Acoustics and Cavitation to Noninvasive Therapy and Drug Delivery , 2008 .

[29]  S. Mitragotri,et al.  Safe and Effective Permeation Enhancers for Oral Drug Delivery , 2008, Pharmaceutical Research.

[30]  J. Kushner,et al.  Evaluation of the porosity, the tortuosity, and the hindrance factor for the transdermal delivery of hydrophilic permeants in the context of the aqueous pore pathway hypothesis using dual-radiolabeled permeability experiments. , 2007, Journal of pharmaceutical sciences.

[31]  I. Gómez-Orellana,et al.  Challenges for the oral delivery of macromolecules , 2003, Nature Reviews Drug Discovery.

[32]  S. Mitragotri,et al.  Ultrasound-mediated transdermal protein delivery , 1995, Science.

[33]  T. Kararli.  Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals , 1995, Biopharmaceutics & drug disposition.

[34]  Anthony I. Eller,et al.  Rectified Diffusion during Nonlinear Pulsations of Cavitation Bubbles , 1963 .

[35]  G PLACITELLI,et al.  [Ulcerative colitis]. , 1958, La Riforma medica.

[36]  C. FordAlexander,et al.  ULCERATIVE colitis. , 1997, Journal of the American Medical Association.